agilon health, inc. (AGL)
$
4.33
-0.16 (-3.70%)
Key metrics
Financial statements
Free cash flow per share
-0.1946
Market cap
1.9 Billion
Price to sales ratio
0.3082
Debt to equity
0.0881
Current ratio
1.2654
Income quality
0.2221
Average inventory
0
ROE
-0.4169
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilon Health, Inc. specializes in providing healthcare services for seniors in communities across the United States through primary care physicians. As of December 31, 2021, the company served approximately 238,000 senior members, which included 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. The company recorded an operating income of -$292,130,000.00 reflecting its earnings from core operations. Additionally, the total costs and expenses for the company are $6,352,660,000.00 reflecting its overall spending. The net total of other income and expenses is $43,304,000.00 reflecting non-core financial activities. The EBITDA is -$218,186,000.00 a key indicator of the company's operational profitability. Furthermore, the weighted average number of diluted shares outstanding is $410,966,000.00 reflecting potential dilution effects. Agilon Health, Inc., which was formerly known as Agilon Health Topco, Inc. until March 2021, was founded in 2016 and is based in Austin, Texas. In the financial market, the stock is affordable at $4.30 making it suitable for budget-conscious investors. Furthermore, the stock has a high average trading volume of $5,640,098.00 indicating strong liquidity. With a market capitalization of $1,785,271,990.00 the company is classified as a small-cap player, which can provide unique opportunities for growth. It is a key player in the $Medical - Care Facilities industry, contributing significantly to the overall market landscape. Moreover, it belongs to the $Healthcare sector, driving innovation and growth within its market niche. Together, these attributes highlight the company's standing and potential for investors seeking involvement in the healthcare sector focused on senior care.
What is agilon health, inc. (AGL)'s stock forecast?
Analysts predict agilon health, inc. stock to fluctuate between $1.50 (low) and $7.73 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is agilon health, inc.'s market capitalization?
As of 2025-04-01, agilon health, inc.'s market cap is $1,785,271,990, based on 412,303,000 outstanding shares.
How does agilon health, inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, agilon health, inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy agilon health, inc. (AGL) stock?
To buy agilon health, inc. (AGL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AGL. Place an order (Market, Limit, etc.).
What is the best time to invest in agilon health, inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did agilon health, inc. perform in the last earnings report?
Revenue: $6,060,530,000 | EPS: -$0.63 | Growth: -1.56%.
Where can I find agilon health, inc.'s investor relations reports?
Visit https://agilonhealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for agilon health, inc.?
You can explore historical data from here
What is the all-time high and low for agilon health, inc. stock?
All-time high: $44.83 (2021-06-18) | All-time low: $1.50 (2024-11-18).
What are the key trends affecting agilon health, inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
benzinga.com
J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.
zacks.com
Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
seekingalpha.com
agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference.
zacks.com
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
globenewswire.com
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating agilon health, inc. (NYSE: AGL) on behalf of the company's long-term shareholders.
businesswire.com
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will release its financial results for the fourth quarter and full year 2024 after the market closes on Tuesday February 25, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for i.
See all news
